Breaking News, Collaborations & Alliances

Laureate, ZZ Biotech Complete Protein Production Pact

Produces Phase I material

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Laureate Biopharma has completed the process development and production of a new potential therapeutic for ischemic stroke with partner ZZ Biotech. The drug, 3K3A-APC, is a form of activated human Protein C with a molecular structure that has been modified to remove the undesirable side effect of bleeding. ZZ Biotech recently began Phase I trials with this material.   Kent E. Pryor, Ph.D., chief operating officer of ZZ Biotech, said, “We are pleased to have been able to take a difficult pr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters